These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 35909476)
1. HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF- Ji X; Cheng K; Gao C; Xie H; Zhu R; Luo J Biomed Res Int; 2022; 2022():5509346. PubMed ID: 35909476 [TBL] [Abstract][Full Text] [Related]
2. SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer. Luo J; Chen B; Gao CX; Xie HK; Han CN; Zhou CC Biochem Biophys Res Commun; 2018 Sep; 504(1):289-294. PubMed ID: 30190126 [TBL] [Abstract][Full Text] [Related]
3. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway. Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491 [TBL] [Abstract][Full Text] [Related]
4. SPOP inhibits mice pancreatic stellate cell activation by promoting FADD degradation in cerulein-induced chronic pancreatitis. Tan P; Wang A; Chen H; Du Y; Qian B; Shi H; Zhang Y; Xia X; Fu W Exp Cell Res; 2019 Nov; 384(1):111606. PubMed ID: 31493386 [TBL] [Abstract][Full Text] [Related]
5. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway. Li J; Li Y; Wang B; Ma Y; Chen P J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161 [TBL] [Abstract][Full Text] [Related]
6. Retracted: HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF- International BR Biomed Res Int; 2023; 2023():9763292. PubMed ID: 38188779 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway. Lu Z; Li Y; Wang J; Che Y; Sun S; Huang J; Chen Z; He J J Exp Clin Cancer Res; 2017 Apr; 36(1):54. PubMed ID: 28412955 [TBL] [Abstract][Full Text] [Related]
8. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway. Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875 [TBL] [Abstract][Full Text] [Related]
9. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth. Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696 [TBL] [Abstract][Full Text] [Related]
10. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer]. Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534 [TBL] [Abstract][Full Text] [Related]
11. MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway. Liu X; Liu J; Zhang X; Tong Y; Gan X J Cell Mol Med; 2019 Jan; 23(1):205-215. PubMed ID: 30407707 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381 [TBL] [Abstract][Full Text] [Related]
13. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway. Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547 [TBL] [Abstract][Full Text] [Related]
14. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins. Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089 [TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking induces aberrant N Jin M; Li G; Liu W; Wu X; Zhu J; Zhao D; Zeng Z; Xiong M; Song Y; He X; Zhang Q; Hu K Cancer Lett; 2021 Oct; 518():214-229. PubMed ID: 34298122 [TBL] [Abstract][Full Text] [Related]
16. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling. Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772 [TBL] [Abstract][Full Text] [Related]
18. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis. Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766 [TBL] [Abstract][Full Text] [Related]
19. miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling. Arora S; Singh P; Tabassum G; Dohare R; Syed MA Life Sci; 2022 Sep; 304():120722. PubMed ID: 35714705 [TBL] [Abstract][Full Text] [Related]
20. miR-675 promotes disease progression of non-small cell lung cancer via activating NF-κB signaling pathway. Feng Y; Yang C; Hu D; Wang X; Liu X Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):7-10. PubMed ID: 28719338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]